ORACION AMER ARPRT ($CAAP) posted quarterly earnings results for Q4 2025 on Tuesday, March 17th. The company reported earnings of $0.65 per share, beating estimates of $0.38 by $0.27. The company also reported revenue of $544,100,000, beating estimates of $498,134,850 by $45,965,150.
You can see Quiver Quantitative's $CAAP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ORACION AMER ARPRT Hedge Fund Activity
We have seen 53 institutional investors add shares of ORACION AMER ARPRT stock to their portfolio, and 60 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FOURTH SAIL CAPITAL LP removed 1,521,602 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $27,571,428
- BNP PARIBAS FINANCIAL MARKETS added 257,699 shares (+52.1%) to their portfolio in Q4 2025, for an estimated $6,700,174
- LRT CAPITAL MANAGEMENT, LLC removed 195,885 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,093,010
- JANE STREET GROUP, LLC removed 141,193 shares (-91.1%) from their portfolio in Q4 2025, for an estimated $3,671,018
- MORGAN STANLEY added 136,323 shares (+39.1%) to their portfolio in Q4 2025, for an estimated $3,544,398
- HELIKON INVESTMENTS LTD added 135,515 shares (+1.0%) to their portfolio in Q4 2025, for an estimated $3,523,390
- POINT72 ASSET MANAGEMENT, L.P. added 120,797 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,140,722
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ORACION AMER ARPRT Price Targets
Multiple analysts have issued price targets for $CAAP recently. We have seen 2 analysts offer price targets for $CAAP in the last 6 months, with a median target of $27.75.
Here are some recent targets:
- Bruno Amorim from Goldman Sachs set a target price of $28.5 on 01/29/2026
- Guilherme Mendes from JP Morgan set a target price of $27.0 on 01/16/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
